Monographie - Anidulafungin - Stabilis 4.0

Poslední aktualizace :
08/05/2024

Priešgrybelinis vaistas

Anidulafungin

Įpurškimas

Tirpalų stabilumas

Mišinių stabilumas

Stabilumą lemiantys veiksniai

Suderinamumas

Leidimo būdai

Bibliografija

Pdf

Cheminė sandara

Prekinis pavadinimas

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anidulafungin	Belgija, Didžioji Britanija, Vokietija
Anidulafungina	Ispanija
Ecalta	Argentina, Belgija, Čilė, Danija, Didžioji Britanija, Graikija, Ispanija, Italija, Jungtinės Amerikos Valstijos, Kanada, Kolumbija, Lenkija, Liuksemburgas, Malaizija, Norvegija, Olandija, Peru, Prancūzija, Rumunija, Suomija, Švedija, Šveicarija, Turkija, Venesuela, Vengrija, Vokietija
Ecaltha	Meksikas
Equalta	Meksikas
Eraxis	Jungtinės Amerikos Valstijos, Kanada

Bibliografija

Įpurškimas

Bibliografija : Anidulafungin

	Tipas	Leidinys
1982	Žurnalas	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2262	Žurnalas	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3567	Laboratorija	Anidulafungin (Ecalta®) - Summary of Product Characteristics. Pfizer 2020
3827	Plakatas	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	Plakatas	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Plakatas	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Žurnalas	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Žurnalas	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4528	Žurnalas	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4801	Žurnalas	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales